TLSI: TriSalus Life Sciences Inc Company Profile & Statistics

About

TriSalus Life Sciences Inc. is an oncology company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors. TriSalus Life Sciences Inc., formerly known as MedTech Acquisition Corporation, is based in CHICAGO.

Info & Links

CEO

Mary Szela

Headquarters

6272 W 91st Ave
Westminster, CO 80031, UNITED STATES

Auditor

KPMG LLP

Share holders

136

Employees

112

TriSalus Life Sciences Inc Statistics

Valuation Measures

Market Capitalization²

114.64M

Enterprise Value

125.03M

Enterprise Value/EBITDA(ttm)

-3.02

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

4.43

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

87.19%

Operating Margin(ttm)

-227.93%

Profit Margin(ttm)

-240.64%

Return on Equity(ttm)

Return on Invested Capital(ttm)

126.52%

Return on Assets(ttm)

-236.83%

Income Statement

Revenue(ttm)

26.89M

Revenue Per Share(ttm)

0.88

Gross Profit(ttm)

23.42M

EBITDA(ttm)³

-41.38M

Net Income Available to Common(ttm)

-58.53M

Diluted EPS(ttm)

-2.49

Share Statistics

Beta (5Y Monthly)

0.56

52-Week Change

-6.00%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

30.49M

Dividend Yield

0.00%

Float⁴

20.49M

% Held by Insiders

32.80%

% Held by Institutions

2.58%

Balance Sheet

Total Cash(mrq)

11.29M

Total Cash Per Share(mrq)

0.37

Total Debt(mrq)

21.68M

Total Debt/Equity(mrq)

-106.09%

Current Ratio(mrq)

2.40%

Quick Ratio(mrq)

2.00%

Book Value Per Share(mrq)

-0.67

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.33

Free Cash Flow(ytd)

-35.43M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

TLSI

TriSalus Life Sciences Inc

TriSalus Life Sciences Inc Profile